This information is sourced from NHS Digital:

Stable HIV

• Patients with stable HIV and no other conditions have not been specifically allocated to the shielded patient list
• We are aware that despite this they are being identified as high risk. This is likely because the code of “immunosuppressed” is used on their record and this is being used to add an entry

Sickle cell trait

• The code for sickle cell disease has been used on the patient’s record rather than sickle cell trait. This has meant patients have been over identified

Peripheral Vascular disease (PVD)

• We have received reports that PVD is being picked up. PVD is not on any of the inclusion criteria. This cannot be explained without further specific investigation

This information is sourced from the British Thoracic Society (BTS):

BTS noted an absence of some respiratory patient groups that should have been included specifically and named as high risk:

• Patients with Interstitial Lung Disease/Sarcoidosis
• Patients with bronchiectasis AND who are on prophylactic antibiotics or have chronic Pseudomonas aeruginosa infection or experience 3 or more exacerbations per year or have associated severe airflow obstruction or significant breathlessness (MRC score 3-5)
• Patients on long term ventilation
• Patients with severe asthma on biologics
• Patients with pulmonary hypertension

This information is sourced from the British Society for Heart Failure:

• Consider shielding for those symptomatic patients at highest risk, including those with an NT-proBNP of >2000pg/ml